Danowski et al. reported that among a group of approximately 400 SLE patients with APS, IgA anti-B2GPI did not associate with any manifestation of APS in contrast to IgG and IgM anti-B2GPI [16]. This evidence concerns the gene CD79A and autoimmune polyendocrinopathy.